Peking University

Silent mutations alter cell fitness in humans, PE...
CMN Briefs

Jun. 24, 2025

A high-throughput prime editing screen in human cells reveals that some synonymous mutations, long considered functionally neutral, can significantly...

Peking University

Renal Cell Carcinoma, RCC, (NCT02867332)
Sponsors:
Peking University
Indicator
IND Enabling
Phase I
Phase II
Phase III
Castration-Resistant Prostate Cancer, CRPC, (NCT02867345)
Sponsors:
Peking University
IND Enabling
Phase I
Phase II
Phase III
B-Cell Non-Hodgkin Lymphoma, NHL, (NCT06014073)
Sponsors:
Chinese PLA General Hospital
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Retinitis Pigmentosa, RP, (NCT05805007)
Sponsors:
Peking University Third Hospital
Indicator
IND Enabling
Phase I
Phase II
Phase III
Muscle-Invasive Bladder Cancer, MIBC, (NCT02863913)
Sponsors:
Peking University
Indicator
IND Enabling
Phase I
Phase II
Phase III
Human Immunodeficiency Virus Infection, HIV, (NCT03164135)
Sponsors:
Affiliated Hospital to Academy of Military Medical Sciences
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine